Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 8/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | AHCY | P23526 | 1/20 | 0.42 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22399998 | 0.84 | P2RY1 (0.52) | P2RY1ADORA3BLMP2RY12LMNA | |
| SCHEMBL19807561 | 0.84 | P2RY1 (0.52) | P2RY1ADORA3BLMP2RY12LMNA | |
| SCHEMBL19465002 | 0.84 | P2RY1 (0.52) | P2RY1ADORA3BLMP2RY12LMNA | |
| SCHEMBL19464889 | 0.84 | P2RY1 (0.52) | P2RY1ADORA3BLMP2RY12LMNA | |
| SCHEMBL19503291 | 0.84 | P2RY1 (0.52) | P2RY1ADORA3BLMP2RY12LMNA | |
| SCHEMBL23098404 | 0.84 | P2RY1 (0.52) | P2RY1ADORA3BLMP2RY12LMNA | |
| SCHEMBL19807393 | 0.80 | P2RY1 (0.50) | P2RY1ADORA3BLMP2RY12LMNA | |
| SCHEMBL24178109 | 0.77 | P2RY1 (0.49) | P2RY1ADORA3BLMP2RY12LMNA | |
| SCHEMBL19464891 | 0.76 | SLC28A1 (0.67) | P2RY1ADORA3AHCY | |
| SCHEMBL22399999 | 0.75 | AHCY (0.73) | P2RY1ADORA3AHCY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024097387-A1 | COMPOSITIONS FOR INTRAVENOUS ADMINISTRATION | ASTROCYTE PHARMACEUTICALS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |